Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy
- 1 May 2003
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 41 (5) , 972-983
- https://doi.org/10.1016/s0272-6386(03)00194-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathyAmerican Journal of Kidney Diseases, 2001
- Efficacy of long-term alternate day prednisolone therapy in childhood IgA nephropathyClinical and Experimental Nephrology, 1998
- Immunosuppressive treatment of Berger's disease*Clinical Pharmacology & Therapeutics, 1996
- Steroid Therapy during the Early Stage of Progressive IgA NephropathyNephron, 1996
- Treatment of Rapidly Progressive IgA NephropathyPublished by S. Karger AG ,1994
- Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisonePediatric Nephrology, 1993
- Alternate-Day Prednisone Therapy in Children With IgA-Associated NephritisAmerican Journal of Kidney Diseases, 1989
- Treatment of severe IgA nephropathy in childrenPediatric Nephrology, 1989
- Moderately Proteinuric IgA Nephropathy: Prognostic Prediction of Individual Clinical Courses and Steroid Therapy in Progressive CasesNephron, 1989
- Steroid Therapy in IgA Nephropathy: A Retrospective Study in Heavy Proteinuric CasesNephron, 1988